mailed
on 05 Jul 2024
Last Applicant/ Owned by
55 Cambridge Parkway
Cambridge
MA
02142
Serial Number
98113071 filed on 02th Aug 2023
Registration Number
N/A
Correspondent Address
Jennifer M. Mikulina
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Providing online non-downloadable computer software for use in the pharmaceuticals and healthcare fields, namely, for molecular research, research and development of pharmaceutical products and chemical compounds, cell analysis, design of chemical structures, and analysis of biological or chemical activity; providing online non-downloadable artificial intelligence software for use in the pharmaceu Read More
Providing online non-downloadable computer software for use in the pharmaceuticals and healthcare fields, namely, for molecular research, research and development of pharmaceutical products and chemical compounds, cell analysis, design of chemical structures, and analysis of biological or chemical activity; providing online non-downloadable artificial intelligence software for use in the pharmaceuticals and healthcare fields, namely, for diagnostic and therapeutic use, and for data mining in connection with pharmaceutical drug discovery, drug development, pharmaceutical market access, chemogenomics, toxicogenomics and drug response prediction; providing online non-downloadable self-learning and artificial intelligence software for use in the field of healthcare for pharmaceuticals and healthcare fields, namely, for molecular research, research and development of pharmaceutical products and chemical compounds, cell analysis, design of chemical structures, and analysis of biological or chemical activity; providing online non-downloadable software using artificial intelligence for use in the biotechnology field for discovering and designing biomolecules
N/A
N/A
Downloadable computer software for use in the pharmaceuticals and healthcare fields, namely, for molecular research, research and development of pharmaceutical products and chemical compounds, design of chemical structures, and analysis of biological or chemical activity; downloadable artificial intelligence software for use in the pharmaceuticals and healthcare fields for molecular research, research and development of pharmaceutical products and chemical compounds, design of chemical structures, and analysis of biological or chemical activity in connection with pharmaceutical drug discovery and development; downloadable artificial intelligence software for use in the field of healthcare for molecular research, research and development of pharmaceutical products and chemical compounds, design of chemical structures, and analysis of biological or chemical activity
N/A
N/A
Pharmaceutical therapeutic preparations, pharmaceutical preparations, medical therapeutics in the nature of pharmaceutical preparations, therapeutic vaccines, and prophylactic vaccines, and medical pharmaceutical preparations in the fields of oncology, infectious disease, virology, cardiology, allergy, immunology, rheumatology, endocrinology, pulmonology, gastroenterology, and dermatology for treating infectious diseases, cancer, asthma, chronic obstructive pulmonary disease, atopic dermatitis, chronic rhinosinusitis with nasal polyps, inflammatory bowel disease, allergic disease, inflammatory disease, respiratory inflammation or fibrosis, cardiovascular diseases, gout, obesity, neurological conditions, and Sjögren's syndrome, all of the aforesaid developed using artificial intelligence technology
N/A
N/A
No 98113071
No Service Mark
No 119073-0062
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
05th Jul 2024 | SUSPENSION LETTER WRITTEN |
05th Jul 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
05th Jul 2024 | LETTER OF SUSPENSION E-MAILED |
03rd Jul 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
03rd Jul 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
03rd Jul 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
08th Apr 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
08th Apr 2024 | NON-FINAL ACTION E-MAILED |
08th Apr 2024 | NON-FINAL ACTION WRITTEN |
03rd Apr 2024 | ASSIGNED TO EXAMINER |